(Q46357678)

21 December 2017

title

Metformin suppresses intestinal polyp growth in ApcMin/+ mice (English)

1 reference

21 December 2017

1 reference

1 reference

10

Hitoshi Nakagama

1 reference

21 December 2017

Atsushi Nakajima

11

Atsushi Nakajima

1 reference

21 December 2017

Hirokazu Takahashi

6

Hirokazu Takahashi

1 reference

21 December 2017

Hiroki Endo

2

Hiroki Endo

1 reference

21 December 2017

Kunihiro Hosono

5

Kunihiro Hosono

1 reference

21 December 2017

Ayako Tomimoto

1

Ayako Tomimoto

1 reference

21 December 2017

Michiko Sugiyama

3

Michiko Sugiyama

1 reference

21 December 2017

Noriko Nakajima

7

Noriko Nakajima

1 reference

21 December 2017

Yoji Nagashima

8

Yoji Nagashima

1 reference

21 December 2017

Toshio Fujisawa

4

Toshio Fujisawa

1 reference

21 December 2017

author name string

Koichiro Wada

9

1 reference

21 December 2017

publication date

18 September 2008

1 reference

21 December 2017

published in

Cancer Science

1 reference

21 December 2017

volume

99

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

page(s)

2136-2141

1 reference

21 December 2017

cites work

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

COX-2 inhibitors--lessons in drug safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

The blooming of the French lilac

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

mTOR, translation initiation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

The Akt-mTOR tango and its relevance to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

The expanding TOR signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00933.X

10.1111/J.1349-7006.2008.00933.X

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017